Advertisement
Organisation › Details
Dynacure SAS
Dynacure develops new treatments for patients suffering from serious orphan disorders. Dynacure’s lead program, Dyn101, is designed to address centronuclear myopathy (CNM), a rare and debilitating disease affecting children and young adults. The Dyn101 development program targets the Dynamin 2 protein using a cEt antisense oligonucleotide candidate developed in collaboration with Ionis Pharmaceuticals. Dynacure is also building a complementary research portfolio targeting other orphan disorders. Dynacure was founded by Kurma Partners, SATT Conectus and Ionis Pharmaceuticals in 2016, based on foundational research conducted atthe Institute of Genetic and Molecular and Cellular Biology (IGBMC) in Strasbourg. *
Start | 2016-10-24 established | |
Industry | Dyn101 antisense oligonucleotide drug (Dynacure / Ionis) | |
Industry 2 | drug development | |
Person | van Rooijen, Stephane (Dynacure 201807 CEO before Confo Therapeutics –201609 CEO STEPPED DOWN 9/16) | |
Region | Illkirch | |
Country | France | |
Street | 300 Boulevard Sébastien Brant Module 2 du bio-incubateur de l’ESBS, Pôle API | |
City | 10413 Illkirch | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Dynacure SAS. (7/6/18). "Press Release: Dynacure Secures €47 Million Financing to Advance Lead Program into Clinical Development". Strasbourg. | ||
Record changed: 2024-03-30 |
Advertisement
More documents for Dynacure SAS
- [1] Dynacure SAS. (7/10/18). "Press Release: Dynacure Names Chris Freitag (MD) Chief Medical Officer". Strasbourg....
- [2] Dynacure SAS. (7/6/18). "Press Release: Dynacure Secures €47 Million Financing to Advance Lead Program into Clinical Development". Strasbourg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top